Longs selling or a bear attack? What rally, did we rally on Monday and Tuesday to the 2.25-2.29 level or was that my imagination? Anyone who's been here a while is quite familiar with this pattern of not holding onto our gains. At some point, this will change.
Thus, after a sympathetic early drop, we have bounced into the mid morning trade. Good thread, always wise to measure against the competition, against which Ganaxolone's trial is somewhat de-risked.
Date Symbol Name Short Volume Long Volume Total Volume Short%
2016-03-22 MRNS Marinus Pharma CS 66448 101035 167483 40
2016-03-21 MRNS Marinus Pharma CS 5984 36821 42805 14
2016-03-18 MRNS Marinus Pharma CS 36010 53826 89836 40
2016-03-17 MRNS Marinus Pharma CS 26966 21111 48077 56
2016-03-16 MRNS Marinus Pharma CS 15891 23561 39452 40
2016-03-15 MRNS Marinus Pharma CS 20823 24252 45075 46
2016-03-14 MRNS Marinus Pharma CS 12324 25967 38291 32
2016-03-11 MRNS Marinus Pharma CS 7483 13682 21165 35
2016-03-10 MRNS Marinus Pharma CS 40439 58332 98771 41
2016-03-09 MRNS Marinus Pharma CS 9537 12122 21659 44
2016-03-08 MRNS Marinus Pharma CS 34262 41033 75295 46
2016-03-07 MRNS Marinus Pharma CS 78412 57826 136238 58
2016-03-04 MRNS Marinus Pharma CS 28020 8092 36112 78
2016-03-03 MRNS Marinus Pharma CS 9551 8711 18262 52
I notice that responsible longs are staying away from specific price predictions, just as Milano is playing it cool as far as giving the expectations for timing of catalysts. It levels the playing field for both sides and requires retail investors to show good faith as with institutions.
Tomorrow will be better, I am forecasting a return to higher valuations beginning tomorrow. The slow sto has turned up and made a bullish cross, the MACD on the daily is cresting above the signal line with a positive histogram, and after today's pullback, there isn't an overbought condition anymore. Unless the broad market has problems, tomorrow should be a good day for our stock.
I am in with 3,000 shares, at $15.11 and today it's rallying back toward my basis. I did book a loss on a much larger core position earlier this year, waited and then this swoon allowed me to buy in lower than I sold for a much smaller holding. I will sell when it gets back to $18-19 maybe, depends on the sentiment around the name then. Never would have imagined this name would attract so much trouble in the sector with their earnings.
Even if we give some back, more time over $2.00 will lift us higher to stay, building that platform of higher support can only be done over time or it becomes unstable and penetrable. Thanks Sarge!
Why are you here posting? Short or trying to save the longs? Give it up, we can make up our own minds it that's your motive. Clearly you don't own shares. Again, why are you here wasting your time if not invested or short?
The CNS space and cancer, tougher but with IMO-2125 their data is amazing in mice, only a matter of time to get some trials in humans and that one drug can put IDRA solidly to levels like CPXX. AVXL, while the recent catalyst didn't materialize, we have everything we need there to get multiples on our money. Three great picks. I am a bit more diversified, don't want huge positions anywhere after what we've been through with IDRA. My bag there is getting lighter thankfully after today's rally. The biotech ETF's all improved today after testing the February lows, as you know that bodes well going forward.
Week's damage was $4.61 or 24.75%, or loss of $734MM in market cap based on 159.29 million outstanding shares. If there is a silver lining in any of this, Friday looked like the downtrend is losing it's momentum, we were actually positive at the start of the day and ever so briefly at 2:30 ET. We closed .66 higher than the low of the day which was 13.36, another positive. This compares favorably with the relative losses of the prior two days which were brutal. This week's candle was the second worst weekly loss since the week of 9-21 to 9-25, 2015 when the shares lost $9.00, wow!
The biggest positive is we left a gap on Tuesday's gap down of $0.88 and these gaps fill 91% of the time, so getting back to 18.23 is just a question of time spent wading through the trough of a vicious bear attack.
As I understand PME, the Company is providing medicines to those who cannot afford them at the Company's expense by writing down the cost of the drug to the end user. This is private enterprise and government cannot penalize a Company for making medicines available to their own peril of lost profits. The DOJ inquiry if it about PME and I don't think it is, would have a difficult case proving any wrongdoing for making sure people who cannot afford medicines are being provided them at a Company discount.
I upped my stake two days ago when it was $0.7967 and am getting a fast reward. Holding 80,000 shares now, had taken small profits earlier and now getting back to a full position. GLAL.
Yesterday we had a bearish MACD crossover but today's price action toward the close may see this reverse to the upside early next week. There is nothing wrong here, no news, just attrition brought to us by the shorts. We could use some more volume, today was 165,500 shares, not bad, but if we are going to have a sustained rally, we need more push from buyers. I see this moving on up through the $2.00 mark within the next couple of months, and 3's by June. Trov is showing some positive action lately but they too have had a recent short attack, now just over. GLAL
Leaving you out then, up nicely today, looking like we missed a great wink of an opportunity yesterday on that plunge to $2.05 that we both missed. It's one day, but now we have IBB and XBI at our backs.
It already is having an effect, welcome to our YMB and good luck on your purchase. On Saturdays, look for a post from 'reppeptgs' to Youtube music selections, doing a weekly wrap up on the stock action. If this is your first or second day in the stock, can you please keep making return appearances?
Thanks Vince for showing your confidence once again, this speaks volumes! We are looking forward to having some great news coming out of the MDA trial, the poster was impressive. Mice is nice, now let's duplicate this in human trials and it will set the stock price free with incontrovertible data.
No news doesn't mean we need to wallow around in the muck, there's people out there willing to recognize our potential and low share price. SAGE tried to rally earlier today but is now up less than 1% so that isn't where our spurt is coming from. The first trade of the day was a good omen.
Thanks Apollo, where can one get this type of analysis? Or, how do you figure it? Trying to add new tricks to my repertoire.
My guess is May-June, assisted by some key PR's at intervals. So, SGYP chart is looking good, ripe even. Will shorts let it rise, there would need to be catalysts to power sentiment.